Utah Life Sciences News & Events

Feb 2, 2024

January 26, 2025

This week’s newsletter included:

Halia Therapeutics Announces $30M Series C Financing
Halia Announces Kevin O’Neill as VP of Project Management
US House passes R&D Tax Fix
Constant Therapeutics Doses First Patient in Phase 2 Clinical Trial
bioMérieux Nominates Two New Executive Committee Members
Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
Myriad Genetics Completes Acquisition of Intermountain Precision Genomics Assets
Utah Innovation Fund Invests $700k in Local, Life Sciences Startups
Seek Labs Invited to Present at BIO CEO & Investor Conference
Inherent Biosciences and Genomic Prediction Announce Commercial Partnership
Legislative Recap
New Resource Launched for Utah Entrepreneurs
University Track from the 2023 Utah Life Sciences Summit
AI Utah Announces Inaugural AI Utah 100 List
ARUP Quarterly Webinar Series
2024 RAPS Utah Leadership Team
Life Sciences Day on Capitol Hill